Trial · NCT02515630
Adverse events49
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 49
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Momelotinib (MMB) | 10 | 41 | |
| other | Nausea | Gastrointestinal disorders | Momelotinib (MMB) | 9 | 41 | |
| other | Vomiting | Gastrointestinal disorders | Momelotinib (MMB) | 7 | 41 | |
| other | Abdominal pain | Gastrointestinal disorders | Momelotinib (MMB) | 6 | 41 | |
| other | Constipation | Gastrointestinal disorders | Momelotinib (MMB) | 3 | 41 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Momelotinib (MMB) | 12 | 41 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Momelotinib (MMB) | 5 | 41 | |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | Momelotinib (MMB) | 3 | 41 | |
| other | Dizziness | Nervous system disorders | Momelotinib (MMB) | 6 | 41 | |
| other | Headache | Nervous system disorders | Momelotinib (MMB) | 6 | 41 | |
| other | Peripheral sensory neuropathy | Nervous system disorders | Momelotinib (MMB) | 3 | 41 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Momelotinib (MMB) | 7 | 41 | |
| other | Neutropenia | Blood and lymphatic system disorders | Momelotinib (MMB) | 5 | 41 | |
| other | Fatigue | General disorders | Momelotinib (MMB) | 8 | 41 | |
| other | Chills | General disorders | Momelotinib (MMB) | 3 | 41 | |
| other | Urinary tract infection | Infections and infestations | Momelotinib (MMB) | 6 | 41 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Momelotinib (MMB) | 7 | 41 | |
| other | Night sweats | Skin and subcutaneous tissue disorders | Momelotinib (MMB) | 3 | 41 | |
| other | Blood creatinine increased | Investigations | Momelotinib (MMB) | 3 | 41 | |
| other | Musculoskeletal pain | Musculoskeletal and connective tissue disorders | Momelotinib (MMB) | 3 | 41 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02515630/events